Methylene blue mitigates lung injury in HCA rats by regulating macrophage pyroptosis via Nrf2/HO-1 and NLRP3 pathways
Biomolecules and Biomedicine · 2025
DOI: 10.17305/bb.2025.11851 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules and Biomedicine, 2025. Verfasst von Fuyan Ding und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Diseases Intensive Care Unit, Zhengzhou University Central China Fuwai Hospital, People's Hospital of Zhengzhou University, He…. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Pyroptosis, NLR Family, Pyrin Domain-Containing 3 Protein, Methylene Blue. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Methylene blue (MB) has antioxidant properties, yet its role in acute lung injury (ALI) induced by hypothermic circulatory arrest (HCA) remains unexplored. This study investigates MB’s effects and underlying regulatory mechanisms in an HCA rat model. Rats received an intravenous bolus of MB (1 mg/kg) 15 min before HCA induction. Physiological parameters were monitored, and bronchoalveolar lavage fluid (BALF) was collected 2 h postoperatively to assess total protein levels, inflammatory cells, and cytokines. Histopathological lung damage was evaluated using hematoxylin–eosin (H&E) and TUNEL staining. Inflammatory markers and oxidative stress indicators were measured via ELISA and dihydroethidium (DHE) staining. Alveolar macrophages (AMs) were isolated to analyze polarization using flow cytometry and immunofluorescence double staining. Pyroptosis in AMs was detected with Yo-Pro-1 and Hoechst 33342 staining. Additionally, Western blotting was performed to examine the nuclear factor erythroid-2 related factor 2 (Nrf2)/heme oxygenase-1 (HO-1) pathway, Nod-like receptor protein 3 (NLRP3) inflammasome, and pyroptosis-related proteins. Following HCA, rats exhibited significant blood gas abnormalities, structural lung damage, increased pathological scores, and higher apoptosis rates. However, MB mitigated these effects, improving physiological parameters and reducing lung histopathology scores. MB also lowered proinflammatory cytokine levels, increased SOD and GSH-Px activity, promoted AM polarization toward the M2 phenotype, and decreased pyroptosis. Mechanistically, MB activated the Nrf2/HO-1 pathway while inhibiting NLRP3 inflammasome activation. Notably, Nrf2 inhibitors and NLRP3 agonists weakened MB’s protective effects by promoting inflammasome activation and pyroptosis, whereas Nrf2 agonists and NLRP3 inhibitors enhanced MB’s beneficial impact. In conclusion, MB attenuates HCA-induced ALI by modulating AM polarization and pyroptosis via Nrf2/HO-1 pathway activation and NLRP3 inflammasome inhibition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Vascular Diseases Intensive Care Unit, Zhengzhou University Central China Fuwai Hospital, People's Hospital of Zhengzhou University, Henan, China.
- Department of Vascular Surgery, Zhengzhou University Central China Fuwai Hospital, People's Hospital of Zhengzhou University, Henan, China.
Zitieren
APA
Ding, F., Wang, H., Qiao, G., & Zhang, Z. (2025). Methylene blue mitigates lung injury in HCA rats by regulating macrophage pyroptosis via Nrf2/HO-1 and NLRP3 pathways. Biomolecules and Biomedicine. https://doi.org/10.17305/bb.2025.11851
Vancouver
Ding F, Wang H, Qiao G, Zhang Z. Methylene blue mitigates lung injury in HCA rats by regulating macrophage pyroptosis via Nrf2/HO-1 and NLRP3 pathways. Biomolecules and Biomedicine. 2025. doi:10.17305/bb.2025.11851
BibTeX
@article{Ding2025,
author = {Ding, Fuyan and Wang, Hong and Qiao, Gang and Zhang, Zhidong},
title = {Methylene blue mitigates lung injury in HCA rats by regulating macrophage pyroptosis via Nrf2/HO-1 and NLRP3 pathways},
journal = {Biomolecules and Biomedicine},
year = {2025},
doi = {10.17305/bb.2025.11851}
}
EUVIMED